Sami Totah details RADCOM (RDCM) share and option holdings
Rhea-AI Filing Summary
RADCOM Ltd director Sami Totah filed an initial ownership report showing 24,250 Ordinary Shares held directly, plus share options over 16,000 Ordinary Shares at an exercise price of 10.01 expiring in 2034 and options over 14,213 shares at 11.89 expiring in 2035. Footnotes also describe 3,500 additional Ordinary Shares issuable as restricted share units that vest monthly until October 15, 2026, and confirm the option grant dates and vesting schedules.
Positive
- None.
Negative
- None.
FAQ
What does Sami Totah report owning in RADCOM (RDCM) on this Form 3?
He reports direct ownership of 24,250 Ordinary Shares of RADCOM. In addition, the filing lists vested and unvested equity awards, including share options and restricted share units that together represent further potential Ordinary Shares if fully vested and exercised over time.
What share option awards for RADCOM (RDCM) does Sami Totah hold?
The filing shows share options over 16,000 Ordinary Shares with an exercise price of 10.01 expiring in 2034, and options over 14,213 Ordinary Shares with an exercise price of 11.89 expiring in 2035, all held as direct ownership positions.
How do the restricted share units for RADCOM (RDCM) vest for Sami Totah?
Footnotes state that 3,500 Ordinary Shares are issuable upon vesting of restricted share units. These RSUs vest on a monthly basis until October 15, 2026, adding to his potential future share ownership as each monthly tranche becomes fully vested.
What are the vesting terms of Sami Totah’s RADCOM (RDCM) options granted in 2024?
Options granted on October 15, 2024 vest on a monthly basis starting November 15, 2024, continuing until October 15, 2026. These options relate to 16,000 underlying Ordinary Shares exercisable at 10.01, providing a gradual vesting schedule over that period.
What does the Form 3 say about Sami Totah’s 2025 RADCOM (RDCM) option grant?
The filing notes that options granted on January 1, 2025 became fully vested as of February 8, 2026. These options cover 14,213 underlying Ordinary Shares with an exercise price of 11.89 and an expiration date in 2035, all held directly.